APH vs CPHI
Amphenol Corporation (APH) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the APH and CPHI stock pages for the full models.
Not investment advice.